Blood Products

Develop, validate and implement high-throughput PCR screening for plasma pools (of human and animal origin) to screen for blood borne viruses with Covance.

The transmission of blood borne viruses through administration of blood-derived products is a major safety concern for manufacturers. A number of regulatory bodies require in-process plasma pool screening for the presence of specific viruses prior to manufacture. Covance's PCR screening service uses in-house, validated extraction processes for animal or human plasma and employs automation or semi-automation to ensure operational efficiency for you.


Develop, characterize, test and validate with Covance, no matter what technique or molecule you're pursuing. Our experience covers a wide range of biomolecules, including:

Home | Animal Welfare | Privacy Statement | Terms of Use | Cookie Statement | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2014 Covance Inc. All rights reserved.